Nuo Therapeutics, Inc.
Nuo Therapeutics, Inc. (AURX) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 58 transactions totaling $4.5M, demonstrating a bullish sentiment with $3.4M in net insider flow. The most recent transaction on Dec 17, 2025 involved a transaction of 68,750 shares valued at $27.5K.
AURX Insider Activity Summary
Who Is Buying AURX Stock?
No significant insider buying has been recorded for AURX in the recent period.
Who Is Selling AURX Stock?
No significant insider selling has been recorded for AURX in the recent period.
Is Nuo Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AURX is bullish with an Insider Alignment Score of 88/100 and a net flow of $3.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
AURX Frequently Asked Questions
Understanding AURX Insider Activity
Insider trading at Nuo Therapeutics, Inc. (AURX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading AURX stock, having executed 58 transactions in the past 90 days. The most active insider is Charles E. Sheedy (Executive), who has made 10 transactions totaling $3.0M.
Related Tools
Track Nuo Therapeutics, Inc. Insider Activity
Get notified when executives and directors at AURX file new Form 4 transactions